Macrophage colony-stimulating factor (m-csf) in plasma and csf of patients with mild cognitive impairment and alzheimeràs disease

Current Alzheimer Research

Volumn 7, Issue 5, 2010, Pages 409-414

  Laske, C ^a   Stransky, E ^a   Hoffmann, N ^a   Maetzler, W ^b   Straten, G ^a   Eschweiler, G W ^a   Leyhe, T ^a  

^a UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^b UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

Age; Alzheimer s disease; A 1 42; Csf; M csf; Mild cognitive impairment; Plasma; Tau protein

Indexed keywords

AMYLOID BETA PROTEIN[1-42]; COLONY STIMULATING FACTOR 1; TAU PROTEIN;

AGED; ALZHEIMER DISEASE; ARTICLE; BLOOD LEVEL; CEREBROSPINAL FLUID ANALYSIS; CLINICAL ARTICLE; COMPARATIVE STUDY; CONCENTRATION (PARAMETERS); CONTROL GROUP; CONTROLLED STUDY; DISEASE MARKER; FEMALE; HUMAN; MALE; MILD COGNITIVE IMPAIRMENT; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY;

EID: 78549247122     PISSN: 15672050     EISSN: None     Source Type: Journal    
DOI: 10.2174/156720510791383813     Document Type: Article

References (18)

1. Petersen RC, Smith GE, Waring SC, Ivnik RJ, Tangalos EG, Kokmen E. Mild cognitive impairment. clinical characterization and outcome. Arch Neurol 56: 303-308 (1999).
2. Albert MS, Blacker D. Mild cognitive impairment and dementia. Annu Rev Clin Psychol 2: 379-388 (2006).
3. Imai Y, Kohsaka S. Intracellular signaling in M-CSF-induced microglia activation: role of Iba1. Glia 40(2): 164-174 (2002).
4. Mitrasinovic OM, Vincent VA, Simsek D, Murphy GM Jr. Macrophage colony stimulating factor promotes phagocytosis by murine microglia. Neurosci Lett 344: 185-188 (2003).
5. Boissonneault B, Filali M, Lessard M, Relton J, Wong G, Rivest S. Powerful beneficial effects of macrophage colony-stimulating factor on -amyloid deposition and cognitive impairment in Alzheimer's disease. Brain, advanced online publication (2009).
6. Kong QL, Zhang JM, Zhang ZX, Ge PJ, Xu YJ, Mi RS, et al. Serum levels of macrophage colony stimulating factor in the patients with Alzheimer's disease. Zhongguo Yi Xue Ke Xue Yuan Xue Bao 24(3): 298-301 (2002).
7. Du Yan S, Zhu H, Fu J, Yan SF, Roher A, Tourtellotte WW, et al. Amyloid-beta peptide-receptor for advanced glycation endproduct interaction elicits neuronal expression of macrophage-colony stimulating factor: a proinflammatory pathway in Alzheimer disease. Proc Natl Acad Sci USA 94(10): 5296-5301 (1997).
8. Murphy GM, Zhang JM, Zhang ZX, Ge PJ, Xu YJ, Ni RS, et al. Expression of macrophage colony-stimulating factor receptor is increased in the AßPPV717F transgenic mouse model of Alzheimer's disease. Am J Pathol 24(3): 298-301 (2000).
9. Zhang JM, Kong QL, Wang H, Qin C, He W. Expression of macrophage colony stimulating factor in brains of PDAPPV717I transgenic mice. Zhongguo Yi Xue Ke Xue Yuan Xue Bao 26(1): 62-65 (2004).
10. Ray S, Britschgi M, Herbert C, Takeda-Uchimura Y, Boxer A, Blennow K, et al. Classification and prediction of clinical Alzheimer's diagnosis based on plasma signaling proteins. Nat Med 13: 1359-1362 (2007).
11. Sunderland T, Linker G, Mirza N, Putnam KT, Friedman DL, Kimmel LH, et al. Decreased beta-amyloid1-42 and increased tau levels in cerebrospinal fluid of patients with Alzheimer disease. J Am Med Assoc 289(16): 2094-2103 (2003).
12. Hansson O, Zetterberg H, Buchhave P, Londos E, Blennow K, Minthon L. Association between CSF biomarkers and incipient Alzheimeràs disease in patients with mild cognitive impairment: a follow-up study. Lancet Neurol 5: 228-234 (2006).
13. Mc Khann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan E.M. Clinical diagnosis of Alzheimeràs disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimeràs Disease. Neurology 34: 30-4 (1984).
14. Folstein MF, Folstein SE, McHugh PR. "Mini-Mental-State". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12: 189-98 (1975).
15. Andreeff M, Welte K. Hematopoietic colony-stimulating factors. Semin Oncol 16(3): 211-229 (1989).
16. Kamps AW, Hendriks D, Smit JW, Vellenga E. Role of macrophage colony-stimulating factor in the differentiation and expansion of monocytes and dendritic cells from CD34+ progenitor cells. Med Oncol 16(1): 46-52 (1999).
17. Simard AR, Soulet D, Gowing G, Julien JP, Rivest S. Bone marrow-derived microglia play a critical role in restricting senile plaque formation in Alzheimer's disease. Neuron 49(4): 489-502 (2006).
18. Lindsay J, Laurin D, Verreault R, Hébert R, Helliwell B, Hill GB, et al. Risk factors for Alzheimer's disease: a prospective analysis from the Canadian Study of Health and Aging. Am J Epidemiol 156(5): 445-453 (2002).